-
scientific fields, with the aim of providing answers to today's major societal challenges. Among these fields, the theme of “Biology-Health” has seen significant development in recent years, with the creation
-
its potential impact on subsequent child development, with the goal of addressing a significant public health challenge. This initiative is part of the Health Innovation 2030 Plan and is based
-
future health axis places a strong emphasis on the development of innovative therapies, including immunotherapy, applied to various pathologies including cancer. The proposed CPJ project is therefore
-
integration of theoretical and experimental approaches to redefine biological questions, develop innovative experimental strategies, and enhance data analysis and modeling of complex biological systems. It aims
-
collaborations, and promoting cutting-edge technological innovation to strengthen the French research community. By implementing this strategy, Inserm seeks to support the sustained development and significantly
-
challenges. Partners include universities, hospitals, and international research organizations. The proposed project develops a bone regeneration strategy by endochondral ossification, combines human cells
-
junior professor, the “Chaire” will be engaged in the training of young scientists and medical doctors through the advanced programs at Sorbonne Paris Nord University. This will facilitate the development
-
investigating the mechanisms underlying cardiac and vascular diseases. It extends ongoing work developed over several years on heart failure with preserved ejection fraction (HFpEF), as well as research conducted
-
support their professional development. Finally, the chair is part of an open and responsible science approach, prioritizing the study of human tissues and translational approaches, thereby strengthening
-
TICI for “Therapeutics Innovation in Cancer Immunology”. This unit aims to understand the dysregulation of the immune system in the field of inflammation, transplantation and cancers for developing